J.M. Bennett

Azacitidine (AZA) Treatment Prolongs Overall Survival (OS) in Higher-Risk MDS Patients Compared with Conventional Care Regimens (CCR): Results of the AZA-001 Phase III Study.

Pierre Fenaux, G J Mufti, Valeria Santini et al. · Blood · 2007 · 102 citations

The Acquisition of Granulocytes by Leukapheresis: A Comparison of Continuous Flow Centrifugation and Filtration Leukapheresis in Normal and Corticosteroid‐Stimulated Donors

J. L. MacPherson, Jacob Nusbacher, J.M. Bennett · Transfusion · 1976 · 37 citations

14 Revised International Prognostic Scoring System (IPSS-R), developed by the International Prognostic Working Group for Prognosis in MDS (IWG-PM)

Peter L. Greenberg, Heinz Tuechler, Julie Schanz et al. · Leukemia Research · 2011 · 26 citations

Prognostic Assessment, Prognostic Biomarkers, Prognostic Evaluation +8

C028 Cytogenetic response to lenalidomide is associated with improved survival in patients with chromosome 5q deletion

Alan F. List, Kenton Wride, G.W. Dewald et al. · Leukemia Research · 2007 · 25 citations

Hematological Malignancy, Chromosome 5Q, Improved Survival +8